慢性UCN2治疗使CRHR2变得不敏感,并改善胰岛素敏感性
Stephen E Flaherty1, Olivier Bezy1, Wei Zheng1
1Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA.
Nature communications
|July 4, 2023
概括
乌洛科丁2 (UCN2) 导致急性胰岛素耐药性,但通过影响小鼠的皮质otropin释放激素受体2 (CRHR2) 信号传递,慢性地改善了葡萄糖耐受性.
科学领域:
- 代谢研究的研究.
- 内分泌学 在内分泌学.
- 分子信号传递是分子信号传递.
背景情况:
- 乌罗皮素2 (UCN2) 是皮质otropin释放激素受体2 (CRHR2) 的一个连接体.
- UCN2对胰岛素敏感性和葡萄糖耐受性的影响是矛盾的.
- 了解UCN2的机制对于代谢健康至关重要.
研究的目的:
- 阐明UCN2对胰岛素敏感性和葡萄糖代谢的双重作用的机制基础.
- 研究CRHR2信号传导在调解UCN2代谢作用中的作用.
- 开发UCN2对代谢调节的影响的统一模型.
主要方法:
- 在雄性小鼠中,急性和慢性给予UCN2.
- 腺病毒介导的UCN2基因传递.
- 对骨肌肉和细胞培养的ex vivo研究.
- 对CRHR2受体招募 (Gs,Gi,β-Arrestin) 和下游信号 (cAMP,胰岛素信号) 的分析.
主要成果:
- 急性UCN2剂量诱导了小鼠和骨肌肉中的全身胰岛素抵抗.
- 慢性UCN2升高解决了代谢并发症,改善了葡萄糖耐受性.
- 根据UCN2度调节的CRHR2信号,在低度处招募Gs,在高度处招募Gi/β-Arrestin.
- 用UCN2进行前期治疗导致CRHR2内部化,减少cAMP和麻木胰岛素信号传递.
结论:
- UCN2对胰岛素敏感性和葡萄糖代谢具有上下文依赖的影响.
- CRHR2的信号动态 (受体的招募和内化) 构成了UCN2对立的代谢作用的基础.
- 一个新的模型调和了UCN2的矛盾效应,提供了对代谢调节的机制性见解.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
Oral Hypoglycemic Agents: Biguanides and Glitazones
238
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
Insulin: Dosing Regimen and Adverse Effects
213
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Glucagon-like Receptor Agonists
365
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
365
GPCR Desensitization
6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
Chronic Pancreatitis I: Introduction
116
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
116


